UK markets close in 2 hours 15 minutes

Achilles Therapeutics plc (ACHL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.32+0.29 (+5.77%)
At close: 04:00PM EST
5.65 +0.33 (+6.20%)
Pre-market: 09:08AM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
Total revenue
0
0
0
Operating expenses
Research development
39,378
22,629
9,072
Selling general and administrative
19,276
11,098
4,703
Total operating expenses
58,654
33,727
13,775
Operating income or loss
-58,654
-33,727
-13,775
Total other income/expenses net
2,909
531
-215
Income before tax
-55,745
-33,196
-13,990
Income tax expense
44
3
0
Income from continuing operations
-55,789
-33,199
-13,990
Net income
-55,789
-33,199
-13,990
Net income available to common shareholders
-55,789
-33,199
-13,990
Basic EPS
-
-1.82
-0.77
Diluted EPS
-
-1.82
-0.77
Basic average shares
-
18,200
18,200
Diluted average shares
-
18,200
18,200
EBITDA
-
-32,955
-13,473